SCHEMBL27099573

SCHEMBL27099573

CCCC1(CCC)CCCN(C(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21733072 0.84
SCHEMBL24327757 0.81 CYP2D6 (0.31)
SCHEMBL14818605 0.79 SMN1; SMN2 (0.31)
SCHEMBL20613739 0.79
SCHEMBL27277294 0.78
SCHEMBL24861048 0.78
SCHEMBL14818604 0.75 CYP2D6 (0.38)
SCHEMBL25465545 0.75
SCHEMBL20840885 0.75
SCHEMBL24688713 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912723-B2 KRAS modulators and uses thereof QUANTA THERAPEUTICS, INC. (US) 2024-02-27 US disclosed